[Aminoguanidine and other AGE inhibitors]

MeSH terms

• Amides / pharmacology
• Animals
• Arteriosclerosis / drug therapy
• Arteriosclerosis / etiology
• Cardiovascular Diseases / drug therapy
• Cardiovascular Diseases / etiology
• Cataract / drug therapy
• Cataract / etiology
• Clinical Trials as Topic
• Diabetes Mellitus / drug therapy
• Diabetes Mellitus / etiology
• Diabetic Nephropathies / drug therapy
• Diabetic Nephropathies / etiology
• Diabetic Retinopathy / drug therapy
• Diabetic Retinopathy / etiology
• Disease Models, Animal
• Drug Design
• Glycation End Products, Advanced / antagonists & inhibitors*
• Guanidines* / adverse effects
• Guanidines* / pharmacology
• Guanidines* / therapeutic use
• Humans
• Hydrazines / pharmacology
• Hypoglycemic Agents* / adverse effects
• Hypoglycemic Agents* / pharmacology
• Hypoglycemic Agents* / therapeutic use
• Thiadiazoles / pharmacology
• Thiazoles / pharmacology
• Thiazoles / therapeutic use
• Thiazolidines